Posts
The Bitcoin Swindlers
FRAUD The Bitcoin Swindlers TL;DR: By now, I imagine you’ve heard of two viral happenings this week: The Netflix documentary on the Tinder Swindler (aka the phony rich kid that defrauded women he met on Tinder). The DOJ arrested Ilya Lichtenstein and Heather Morgan (aka Razzlekhan) for allegedly conspiring to launder $4.5B in stolen cryptocurrency. Both stories coming at us this week…
Read MoreBusting The Myths: Is Cannabis Bad for Society?
CANNABIS POLICIES The Dangers Of Cannabis Breaking Down The Claims That Cannabis Negatively Impacts Society… It’s been a long time since society has seen a poster like this and taken it seriously. This poster is from the “Reefer Madness” era of the 1930s when cannabis was quite literally demonized across the United States. The message…
Read MoreLooking at Social Equity in Cannabis in 2022
Cannabis Data Top Cannabis Brands Breaking Down The Consumer Demand For Social Equity Cannabis Brands… February is Black History Month. In 1926, Black author, historian, editor, and publisher, Dr. Carter G. Woodson suggested there be a time dedicated to reflecting the historical accomplishments of Black individuals and groups. Both Abraham Lincoln, who issued the Emancipation…
Read MoreWhat’s missing in media? Creativity
Media companies are in the business of creativity. Whether it’s going from a blank Google Doc to an essay filled with insights, or from a notepad with rhymes to the most successful Broadway play of all time, creativity is the core of every media business. Yet, when it comes to the business of media creativity…
Read MoreWeek of 2/9/2022: Perpetual’s Perspective
FOS is bought by Crain’s TLDR: Crain Communications bought a 20% stake in Front Office Sports for $5M, a media company covering the business of sports primarily via newsletters and social channels. The deal valued FOS at $25M. As part of the deal, the CEO of Crain Communications will join the board. Perpetual’s Perspective: Adam White and…
Read MoreBiogen Sells Out and Buys In
BUSINESS Biogen Sells Out and Buys In Biogen is selling its equity stake in a joint venture with Samsung Biologics and buying into Roche’s cancer drug mosunetuzumab. These business moves will likely bring in billions of dollars of revenue over the years, helping the company bounce back from the financial struggles of its Alzheimer’s drug…
Read More